Travoprost implant plus iStent for glaucoma
Part of Eyes & vision clinical trials.
This trial tests a tiny implant that slowly releases travoprost (a pressure-lowering medicine) inside the eye, combined with a small stent (iStent) to help drain fluid. It's for people with open-angle glaucoma or high eye pressure who need to lower their eye pressure.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with open-angle glaucoma or high eye pressure (ocular hypertension).
- Your eye pressure is high enough when measured without medication.
- You are not allergic to travoprost or any other part of the eye implant.
- Your optic nerve is not severely damaged (cup-to-disc ratio must be 0.8 or less).
- Your vision in both eyes must be better than 20/80 (with glasses or contacts).
- You do not have any other eye disease that could make the study unsafe or affect results.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if a tiny implant called iDose® TR, placed during cataract surgery, can better control eye pressure in people with glaucoma or high eye pressure compared to cataract surgery alone.
This trial tests a newer version of a tiny implant placed inside the eye to lower pressure in people with open-angle glaucoma or ocular hypertension. It may offer a treatment option that doesn't require daily eye drops.
This trial tests a tiny implant that slowly releases medication inside the eye to lower pressure. It is for people with open-angle glaucoma or high eye pressure who have not had certain eye surgeries.
This trial studies a new treatment (a tiny device called iStent Infinite and a medication implant) for people with moderate to severe open-angle glaucoma who have not responded well to drops or laser. The goal is to see if this treatment can lower eye pressure and help avoid traditional surgery.
This trial studies a tiny implant called iStent Infinite that helps drain fluid from the eye to lower pressure in people with mild to moderate open-angle glaucoma. It may offer a new way to manage the condition.
This trial is testing a new way to deliver a medication (travoprost) directly into the eye using a small implant. It's for people with open-angle glaucoma and aims to see how well the updated inserter works.
Hear when a new Glaucoma, Open-Angle trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.